Form CORRESP - Correspondence:
SEC Accession No. 0001140361-25-012884
Filing Date
2025-04-08
Accepted
2025-04-08 18:00:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5406
2 ny20043442x4_image01.jpg GRAPHIC 34391
  Complete submission text file 0001140361-25-012884.txt   54132
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)